机构：[1]State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China四川大学华西医院[2]Department of Pathology, West China Second Hospital, Sichuan University, Chengdu, Sichuan, China[3]Department of Neurology, West China Hospital, Sichuan University, Chengdu, Sichuan, China四川大学华西医院[4]Department ofThyroid and Parathyroid Surgery, Laboratory of thyroid and parathyroid disease, Frontiers Science Center for Disease- related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, China四川大学华西医院[5]Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China四川大学华西医院[6]Department of Gastroenterology, The Afiliated Hospital of Southwest Medical University, Luzhou, Sichuan Province, China[7]Sichuan Center for Translational Medicine of Traditional Chinese Medicine, Institute of Translational Pharmacology, Sichuan Academy of Chinese Medicine Sciences, Chengdu, China[8]Department of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Xiangya Hospital, Central South University, Changsha, China[9]Department of Laboratory Medicine, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China四川大学华西医院
We thank all members of the Core Facilities of West China Hospital
for technical assistance, particularly Sisi Wu, Hongying Chen, and Jie
Zhang. This work was supported by grants from the National Key
Research Development Program of China (No.2021YFA1301203), the
National Natural Science Foundation of China (No. 81903735,
82002569, 81902437, and 82073246), Sichuan Science & Technology
Program (No. 2021Y]0475, 22ZDYF2654, 22CXRC0248), and 1.3.5 Project for Disciplines of Excellence, West China Hospital, Sichuan
University (No. ZYYC20003， ZY]C18004， ZY]C21006, ZY]C21024,
ZYGD20006, ZYYC20007). .
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2022]版：
大类|2 区医学
小类|1 区妇产科学2 区肿瘤学
最新[2023]版：
大类|2 区医学
小类|1 区妇产科学2 区肿瘤学
第一作者：
第一作者机构：[1]State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China[2]Department of Pathology, West China Second Hospital, Sichuan University, Chengdu, Sichuan, China
共同第一作者：
通讯作者：
通讯机构：[1]State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China[5]Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China[9]Department of Laboratory Medicine, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China[*1]Department of Gastrointestinal Surgery, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, No.17, Section 3, South Renmin Road, Chengdu 610041, China.[*2]Department ofLaboratory Medicine, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, No. 17, Section 3, South Renmin Road, Chengdu, 610041, Sichuan, China.[*3]Institute ofranlational Phamacology, Sichuan Academy of Chinese Medicine Sciences, No.51, Setion 4, South Renmin Road, Chengdu 610041,
推荐引用方式(GB/T 7714)：
Liao Xin,Xia Xuyang,Su Wei,et al.Association of recurrent APOBEC3B alterations with the prognosis of gastric-type cervical adenocarcinoma.[J].Gynecologic oncology.2022,165(1):105-113.doi:10.1016/j.ygyno.2022.01.036.
APA：
Liao Xin,Xia Xuyang,Su Wei,Yan Huayun,Ma Yingfang...&Shu Yang.(2022).Association of recurrent APOBEC3B alterations with the prognosis of gastric-type cervical adenocarcinoma..Gynecologic oncology,165,(1)
MLA：
Liao Xin,et al."Association of recurrent APOBEC3B alterations with the prognosis of gastric-type cervical adenocarcinoma.".Gynecologic oncology 165..1(2022):105-113
医学